Novel Resistant Potato Starches on Glycemia and Satiety in Humans

This study was designed to determine the efficacy of two novel type-four resistant starches (RS4) on postprandial glycemia and ratings of fullness. Volunteers (n=10) completed completed five interventions designed to determine the glycemic and satiety (fullness) effects of the starches (38 g,) alone...

Full description

Bibliographic Details
Main Authors: Mark D. Haub, Julie A. Louk, Tara C. Lopez
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Journal of Nutrition and Metabolism
Online Access:http://dx.doi.org/10.1155/2012/478043
id doaj-c4e28545d0b747deaa8adb6bbd942931
record_format Article
spelling doaj-c4e28545d0b747deaa8adb6bbd9429312020-11-24T23:03:47ZengHindawi LimitedJournal of Nutrition and Metabolism2090-07242090-07322012-01-01201210.1155/2012/478043478043Novel Resistant Potato Starches on Glycemia and Satiety in HumansMark D. Haub0Julie A. Louk1Tara C. Lopez2Food and Metabolism Laboratory, Department of Human Nutrition, Kansas State University, 206 Justin Hall, Manhattan, KS 66506-1400, USAFood and Metabolism Laboratory, Department of Human Nutrition, Kansas State University, 206 Justin Hall, Manhattan, KS 66506-1400, USAFood and Metabolism Laboratory, Department of Human Nutrition, Kansas State University, 206 Justin Hall, Manhattan, KS 66506-1400, USAThis study was designed to determine the efficacy of two novel type-four resistant starches (RS4) on postprandial glycemia and ratings of fullness. Volunteers (n=10) completed completed five interventions designed to determine the glycemic and satiety (fullness) effects of the starches (38 g,) alone and when added on top of available carbohydrate. The dose of the starches provided 30 g of resistant starch per treatment. The treatments were: commercial resistant starch added to water (PF−), noncommercial resistant starch added to water (PR−), dextrose solution (DEX, 50 g), and DEX with PenFibe starch (PF+), and DEX with the non-commercial starch added (PR+). Blood glucose was measured in the fasted state and following the randomly assigned treatments at 30, 45, 60, 90, and 120 minutes post-consumption. A visual analog scale was used to determine fullness at each time point. There were no differences in the glucose incremental areas under the curve (iAUC) for PF+ and PR+ compared with DEX. The PF− and PR− treatments had decreased (P<0.05) iAUCs for glucose compared with DEX, PF+, and PR+. There were no treatment differences for RoF. The dose (38 g) of starches did not to alter glucose responses when added on top of 50 g of dextrose.http://dx.doi.org/10.1155/2012/478043
collection DOAJ
language English
format Article
sources DOAJ
author Mark D. Haub
Julie A. Louk
Tara C. Lopez
spellingShingle Mark D. Haub
Julie A. Louk
Tara C. Lopez
Novel Resistant Potato Starches on Glycemia and Satiety in Humans
Journal of Nutrition and Metabolism
author_facet Mark D. Haub
Julie A. Louk
Tara C. Lopez
author_sort Mark D. Haub
title Novel Resistant Potato Starches on Glycemia and Satiety in Humans
title_short Novel Resistant Potato Starches on Glycemia and Satiety in Humans
title_full Novel Resistant Potato Starches on Glycemia and Satiety in Humans
title_fullStr Novel Resistant Potato Starches on Glycemia and Satiety in Humans
title_full_unstemmed Novel Resistant Potato Starches on Glycemia and Satiety in Humans
title_sort novel resistant potato starches on glycemia and satiety in humans
publisher Hindawi Limited
series Journal of Nutrition and Metabolism
issn 2090-0724
2090-0732
publishDate 2012-01-01
description This study was designed to determine the efficacy of two novel type-four resistant starches (RS4) on postprandial glycemia and ratings of fullness. Volunteers (n=10) completed completed five interventions designed to determine the glycemic and satiety (fullness) effects of the starches (38 g,) alone and when added on top of available carbohydrate. The dose of the starches provided 30 g of resistant starch per treatment. The treatments were: commercial resistant starch added to water (PF−), noncommercial resistant starch added to water (PR−), dextrose solution (DEX, 50 g), and DEX with PenFibe starch (PF+), and DEX with the non-commercial starch added (PR+). Blood glucose was measured in the fasted state and following the randomly assigned treatments at 30, 45, 60, 90, and 120 minutes post-consumption. A visual analog scale was used to determine fullness at each time point. There were no differences in the glucose incremental areas under the curve (iAUC) for PF+ and PR+ compared with DEX. The PF− and PR− treatments had decreased (P<0.05) iAUCs for glucose compared with DEX, PF+, and PR+. There were no treatment differences for RoF. The dose (38 g) of starches did not to alter glucose responses when added on top of 50 g of dextrose.
url http://dx.doi.org/10.1155/2012/478043
work_keys_str_mv AT markdhaub novelresistantpotatostarchesonglycemiaandsatietyinhumans
AT juliealouk novelresistantpotatostarchesonglycemiaandsatietyinhumans
AT taraclopez novelresistantpotatostarchesonglycemiaandsatietyinhumans
_version_ 1725632168353333248